Primavera Rosita, Di Francesco Martina, De Cola Antonella, De Laurenzi Vincenzo, Paolino Donatella, Ciancaioni Matteo, Carafa Maria, Celia Christian, Di Ilio Carmine, Di Stefano Antonio, Fresta Massimo, Locatelli Marcello, Di Marzio Luisa
Department of Pharmacy, University of Chieti - Pescara "G. d'Annunzio", Chieti 66013, Italy.
Department of Health Sciences, University of Catanzaro "Magna Graecia", Germaneto - Catanzaro, 88100, Italy.
Colloids Surf B Biointerfaces. 2015 Nov 1;135:575-580. doi: 10.1016/j.colsurfb.2015.08.006. Epub 2015 Aug 8.
The analytical tools allow the detection of bioactive compounds, diagnostic agents and chemotherapeutics. Recently, new methods have been developed to analyze pharmaceutical samples and ingredients. In this attempt, analytical parameters, e.g., the lack of trueness, robustness and sensitivity, play a pivotal role to quantify and analyze molecules, both for diagnostic applications as well as therapeutic treatments. Spectrophotometers and spectrofluorometers are apparatus for easy and rapid quantification of molecular probes and chemotherapeutics into cells, plasma and tissues. However, they lack accuracy and precision. Conversely, HPLC provides the maximum resolution to detect and separate fluorescent probes and chemotherapeutics after their incubation in cells, plasma and tissues. The aim of this work was to develop an HPLC method that easily detects molecular and fluorescent probes, e.g., Nile Red, in biological samples. To improve the robustness of the method, Nile Red was analyzed before and after loading into niosomes made from Tween 20 and 21, respectively. A significant difference was further obtained by comparing the entrapment efficacy percentage of niosomes made from Tween 21 (42.23%) and Tween 20 (53.25%). The comparison between HPLC and spectrofluorometer assays showed differences between the two methods in terms of limit of detection, linearity and accuracy. The resulting data demonstrated that the HPLC-FLD provides a limit of detection for Nile Red of 0.1 ng/mL, and a good linearity up to 62.5 ng/mL. The HPLC-FLD analysis showed a limit of quantification value for a total mass of Nile Red 1200-folds better than data previously reported in studies; and 312-folds better than the spectrofluorometer analysis. Additionally, results show that the HPLC-FLD increases the sensitivity for biological samples compared to the spectrofluorometer. The Nile Red-loaded niosomes were also incubated at different times with HEK-293 cells. In vitro results demonstrated that the HPLC-FLD apparatus detects Nile Red-loaded niosomes at higher concentrations into HEK-293 cells than the spectrofluorometer. The intracellular uptake of Nile Red was increased at 120 and 24 min using niosomes made from Tween 20 and 21, respectively, and its intracellular accumulation shows a time-dependent internalization over 120 min of incubation time.
这些分析工具可用于检测生物活性化合物、诊断试剂和化疗药物。最近,已开发出用于分析药物样品和成分的新方法。在这一过程中,分析参数,例如缺乏准确性、稳健性和灵敏度,对于定量和分析分子起着关键作用,无论是用于诊断应用还是治疗。分光光度计和荧光分光光度计是用于将分子探针和化疗药物轻松快速定量到细胞、血浆和组织中的仪器。然而,它们缺乏准确性和精密度。相反,高效液相色谱(HPLC)在荧光探针和化疗药物在细胞、血浆和组织中孵育后,能提供最高分辨率来检测和分离它们。这项工作的目的是开发一种HPLC方法,用于轻松检测生物样品中的分子和荧光探针,例如尼罗红。为提高该方法的稳健性,分别在尼罗红载入由吐温20和吐温21制成的脂质体前后对其进行分析。通过比较由吐温21(42.23%)和吐温20(53.25%)制成的脂质体的包封率,进一步获得了显著差异。HPLC和荧光分光光度计测定法之间的比较表明,两种方法在检测限、线性和准确性方面存在差异。所得数据表明,HPLC-荧光检测器(HPLC-FLD)对尼罗红的检测限为0.1 ng/mL,在高达62.5 ng/mL范围内具有良好的线性。HPLC-FLD分析显示,尼罗红总质量的定量限数值比之前研究报告的数据好1200倍;比荧光分光光度计分析好312倍。此外,结果表明,与荧光分光光度计相比,HPLC-FLD提高了对生物样品的灵敏度。载入尼罗红的脂质体也与HEK-293细胞在不同时间孵育。体外结果表明,HPLC-FLD仪器检测到载入尼罗红的脂质体在HEK-293细胞中的浓度高于荧光分光光度计。使用由吐温20和吐温21制成的脂质体时,尼罗红在细胞内的摄取分别在120分钟和24分钟时增加,并且其细胞内积累在120分钟的孵育时间内呈现出时间依赖性内化。